Videoconferencia para la gestión de la disnea pediátrica en un centro de llamadas médicas de emergencia (VISIODYS-PED)
Videoconferencia para la gestión de la disnea pediátrica en un centro de llamadas médicas de emergencia: el protocolo de estudio controlado aleatorizado de Visiodys preparados
Dyspnoea is defined as the sensation of difficult or uncomfortable breathing experienced by a patient. It is a significant concern in emergency care, accounting for 8% of calls to the emergency medical call centre (EMCC) and 10% of Emergency department (ED) admissions. Among paediatric patients, dyspnoea accounts from 14-27% of ED admissions, exhibiting notable seasonal variation. Approximately 10% of these patients require hospitalisation, and 1-3% of cases progress to respiratory failure. All these patients require a comprehensive clinical examination to accurately identify signs of severity, ensuring the timely initiation of specialized and effective treatment.
In France, patients are encouraged to contact the local EMCC before visiting an ED. Medical dispatchers assess the clinical condition by phone, based on medical history, symptoms and current treatment. Based on this assessment, the medical dispatcher determines the appropriate decision which may include providing medical advice, directing the patient to an ED, or deploying a mobile intensive care unit (MICU). Seven percent of calls to an EMCC involve paediatric cases, with nearly half concerning children under six years of age with hyperthermia and dyspnoea as most complaints, particularly during epidemic periods. The medical assessment of paediatric dyspnoea by EMCC is particularly challenging. The inability of children to articulate their symptoms, coupled with parents difficulty in describing the situation - often exacerbated by anxiety - creates significant obstacles. Furthermore, the absence of a direct observation by the physician adds to the complexity and could lead to an inappropriate triage and management.
Telemedicine uses communication technologies for remote consultations, electronic record management, and document sharing. It enables real-time visual evaluation, thereby improving diagnostic accuracy and decision-making. While evidence supports its benefits in managing adult dyspnoeic patients, further research is essential to validate its efficacy in paediatric settings, particularly within EMCC.
This study will aim to evaluate the effectiveness of telemedicine within an EMCC and utilising real-time visualization in reducing inappropriate triage of children requiring care for acute dyspnoea.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This is a superiority, prospective, individually randomized, open-label and monocentric study.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
France
-
Poitiers, France, Francia, 86021
- CHU Poitiers
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Children aged between 3 months to 5 years
- Call from parent(s) to an EMCC for dyspnea or shortness of breath or difficulty breathing as main complaint
- Parent or witness with a phone/tablet equipped with a camera
- Emergency consent or oral consent given by the holder(s) of parental authority to the physician dispatcher
Exclusion Criteria:
- Child in life-saving emergency
- Known absence of a telephone network required for the use of video calls
- Call made by an individual who does not hold parental authority
- Communication difficulties with the holder(s) of parental authority, not allowing for a clear and fair information
- Person not benefiting from a social security scheme or through a third party
- Child who has already participated in the study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Standard medical dispatching process (Control group)
The emergency physician dispatcher conducts a standard medical dispatching process. |
|
|
Experimental: Addition of telemedicine to standard medical dispatching process (Experimental Group)
The emergency physician dispatcher conducts a standard medical dispatching process with the addition of telemedicine using video calls. |
In the experimental group, the same approach is used, with the addition of telemedicine using video calls. Callers are invited to use their smartphone camera to enable real-time video assessment. The medical dispatcher sends a secure link (via a platform provided by Enovacom, Nomadeec, Bordeaux, France) to the caller's smartphone, allowing video streaming through a secure internet connection. Once the link is validated by the caller, the live video feed from the smartphone camera is transmitted directly to the dispatcher's computer screen, providing a visual evaluation to support clinical decision-making. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Proportion of patients inaccurately managed
Periodo de tiempo: 24 hours
|
The primary endpoint is the proportion of patients inaccurately managed (over-triage or under-triage) Over-triage is defined as a situation where a patient is:
Under-triage is defined as a situation where a patient is kept at home with medical advice or directed to a family practitioner after the primary call AND later dispatched to hospital by a family practitioner or after a second call to an EMCC for dyspnoea, or hospitalised or dead within 24h following the primary call. |
24 hours
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Proportion of patients who called a second time the emergency communication center for dyspnea
Periodo de tiempo: 24 hours
|
24 hours
|
|
|
Proportion of deceased patients at day 28
Periodo de tiempo: 28 days
|
28 days
|
|
|
Proportion of patients hospitalized within 28 days
Periodo de tiempo: 28 days
|
28 days
|
|
|
Proportion of patients in over-triage situation
Periodo de tiempo: 24 hours
|
Over-triage is defined as a situation where a patient is: (a) Directed to an ED following the call, but does not require any specific treatment, diagnostic tests, or hospitalisation, within 24h following the primary call, or (b) Managed by the deployment of a MICU, despite not requiring specific treatment or transfer to an ED, within 24h following the primary call. |
24 hours
|
|
Proportion of patients in under-triage situation
Periodo de tiempo: 24 hours
|
Under-triage is defined as a situation where a patient is kept at home with medical advice or directed to a family practitioner after the primary call AND later dispatched to hospital by a family practitioner or after a second call to an EMCC for dyspnoea, or hospitalised or dead within 24h following the primary call. |
24 hours
|
|
Medical decision at the end of the call
Periodo de tiempo: At the end of the call to emergency communication center
|
Proportion of patients in each situation at the end of the call: medical advice, referred to a non-hospital-based care, dispatched to an emergency department, emergency medical service. |
At the end of the call to emergency communication center
|
|
Duration of the call
Periodo de tiempo: At the end of the call
|
The duration of the call to emergency communication center, defined as the time between the beginning of the call and the medical decision (in minutes) |
At the end of the call
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Nicolas Marjanovic, MD PhD, Poitiers University Hospital
- Investigador principal: Erwan Ripley, MD, Poitiers University Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- VISIODYS-PED
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Desidentified participant data will be available from the corresponding author upon reasonable request, after approval of a proposal and signature of a data access agreement
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .